Avillion appoints Allison Jeynes-Ellis as Chief Executive
Dr Jeynes-Ellis has over 20 years of senior leadership experience in the pharmaceutical industry. She has managed both large and small teams focusing on global clinical development projects that have led to new drug approvals in Europe and the USA, across a range of therapeutic areas. Dr Jeynes-Ellis is a founding member of Avillion’s management team and was formerly the company’s Chief Medical Officer.